Market Place
Sourcing Support
Oral GLP-1 Race Heats Up As Lilly`s Foundayo Shines In Seniors
25 May 2026 //
INDPHARMAPOST
Lilly To Present Oncology Portfolio At ASCO Meeting 2026
22 May 2026 //
PR NEWSWIRE
Eli Lilly Names Chandan S. Senior Director of Data Science and AI
22 May 2026 //
INDPHARMAPOST
Lilly, BMS, Incyte Strike Deals to Keep AI Momentum Rolling
22 May 2026 //
BIOSPACE
Lilly Says Next-Gen Obesity Drug Helps Patients Lose 28% Weight
22 May 2026 //
REUTERS
Lilly Accuses Church Pharmacies of $200M Rebate Fraud
21 May 2026 //
FIERCE PHARMA
CDD Partners with Lilly TuneLab to Share AI/ML Models
20 May 2026 //
PR NEWSWIRE
Eli Lilly FCA Judgment Finalized at $220M+ After SCOTUS Denial
19 May 2026 //
PR NEWSWIRE
Two Pharma Firms Own Nearly 100% of GLP-1 Citations in AI
19 May 2026 //
PR NEWSWIRE
US Supreme Court Rejects Eli Lilly`s Whistleblower Law Challenge
18 May 2026 //
REUTERS
Lilly to Participate in Bernstein`s 42nd Annual Conference
18 May 2026 //
PR NEWSWIRE
Eli Lilly Introduces Lormalzi For Early Alzheimer`s Treatment
15 May 2026 //
INDPHARMAPOST
The Rise of GPCRs, Radiopharma & Peptide Screening
14 May 2026 //
BIOSPACE
Lilly Sustains Weight Loss Lead With Foundayo, Zepbound
13 May 2026 //
BIOSPACE
Low Weight Regain Seen After Switch to Obesity Pill
13 May 2026 //
REUTERS
Eli Lilly Pledges 500K Meals and Cold Storage for 150 Pantries
12 May 2026 //
PR NEWSWIRE
Lilly Eyes Low-Dose Zepbound, Foundayo for Weight Loss
12 May 2026 //
ENDPOINTS
Eli Lilly Halts India Obesity Campaign Amid Regulatory Scrutiny
12 May 2026 //
ECONOMICTIMES
Lilly`s Foundayo & Low-Dose Zepbound Help Maintain Weight Loss
12 May 2026 //
PR NEWSWIRE
Omada Health Joins Lilly Employer Connect for GLP-1 Care
07 May 2026 //
GLOBENEWSWIRE
Novo and Lilly Gain on Weight-Loss Pill Market Signals
07 May 2026 //
REUTERS
Lilly Pledges $4.5 Billion More To Indiana Manufacturing Campus
06 May 2026 //
PR NEWSWIRE
Foundayo`s Liver Failure Blip Impacts Lilly Shares, Analysts
05 May 2026 //
BIOSPACE
Lilly Declares Second-Quarter 2026 Dividend
04 May 2026 //
PR NEWSWIRE
Lilly`s Obesity Pill Hits 6,000 Prescriptions in Third Month
01 May 2026 //
REUTERS
Eli Lilly Canada`s Kisunla Approved in Canada
30 Apr 2026 //
HEALTH CANADA
Lilly Backs Haryana State-Fda Against Counterfeit Medicines
30 Apr 2026 //
EXPRESSPHARMA
FDA Proposes Limits On Bulk Compounding Of Novo, Lilly
30 Apr 2026 //
REUTERS
Lilly Initiates Phase 2 Trial For CFTX-1554 In Peripheral Pain
30 Apr 2026 //
GLOBENEWSWIRE
Lilly`s Weight Loss Pill Launches Without Full FDA Approval
30 Apr 2026 //
BIOSPACE
Lilly Reports Q1 2026 Results, Raises Full-Year Guidance
30 Apr 2026 //
PR NEWSWIRE
Lilly`s Q1 Revenue Surges By 56% Despite Price Decline
30 Apr 2026 //
BIOSPACE
Lilly Raises Profit Forecast Due To Strong Demand
30 Apr 2026 //
REUTERS
AC Immune First Quarter 2026 Financial And Corporate Updates
30 Apr 2026 //
GLOBENEWSWIRE
Early sales of Lilly’s obesity pill appear to trail Novo’s
30 Apr 2026 //
ENDPOINTS
Lilly Investors Seek Foundayo Clarity After Early Launch Data
29 Apr 2026 //
REUTERS
Biogen Primed to Capture Patients Leaving Lilly`s Kisunla
29 Apr 2026 //
BIOSPACE
Lilly Inks Deals; Regeneron Secures Historic Q1 Win
29 Apr 2026 //
BIOSPACE
Biogen Targets Patients Transitioning Off Lilly`s Kisunla
29 Apr 2026 //
BIOSPACE
Boehringer, Zealand`s Obesity Drug Resembles Novo`s Wegovy
29 Apr 2026 //
BIOSPACE
Profluent, Lilly Partner In $2.25B Genetic Medicine Deal
29 Apr 2026 //
REUTERS
FuturHealth Expands Access to Lilly`s Oral GLP-1 Orforglipron
28 Apr 2026 //
PR NEWSWIRE
Sun Pharma, Eli Lilly Lead Latest Rush Of Health-Care M&A
27 Apr 2026 //
BLOOMBERG
Eli to buy Ajax Pharma for up to $2.3 billion in blood cancer
27 Apr 2026 //
REUTERS
Lilly`s Obesity Pill Shows Modest Performance In Second Week
24 Apr 2026 //
REUTERS HEALTHCARE
Roche Backs Amylin Drug for Low-Side-Effect Obesity Care
23 Apr 2026 //
BIOSPACE
Different Packaging, Typos Expose Fake Mounjaro Racket
23 Apr 2026 //
ECONOMICTIMES
Neura Health To Expand Access To Migraine Care Via Lillydirect
23 Apr 2026 //
GLOBENEWSWIRE
Lilly reneges on remainder of Rigel RIPK1 deal
22 Apr 2026 //
FIERCE BIOTECH
Eli Lilly Issues Statement On Counterfeit Mounjaro Case
21 Apr 2026 //
ECONOMICTIMES
Eli to buy Boston`s Kelonia for up to $7 Billion in Cancer Push
21 Apr 2026 //
BIOSPACE
Eli Lilly flags counterfeit Mounjaro seizure in Gurugram
20 Apr 2026 //
INDPHARMAPOST
Study Suggests Lilly`s Tirzepatide Causes More Lean Muscle Loss
17 Apr 2026 //
ENDPOINTS
In Lilly patent spat, appeals court revives $177M verdict to Teva
17 Apr 2026 //
FIERCE PHARMA
Lilly`s Foundayo Pill Reduces Heart Attack, Stroke Risk In Study
16 Apr 2026 //
REUTERS
Lilly Sets Conference Call For Q1 2026 Financial Results
16 Apr 2026 //
PR NEWSWIRE
ATUM Welcomes Gavin Barnard, Ph.D., As Chief Scientific Officer
16 Apr 2026 //
GLOBENEWSWIRE
Lilly`s Foundayo pill lowers heart attack, stroke risk in study
16 Apr 2026 //
ENDPOINTS
Shed Expands Oral GLP-1 Access Nationwide With Foundayo
15 Apr 2026 //
PR NEWSWIRE
Lilly Buys ADC Specialist Crossbridge Bio In Vague $300M Deal
15 Apr 2026 //
FIERCE BIOTECH
